Clinical Outcomes, Graft Longevity, and Chondral Protection Following Primary or Revision Meniscal Allograft Transplantation Surgery
Part of paid clinical trials in Plano, Texas.
- Sponsor
- Joint Restoration Foundation, Inc.
- Study ID
- NCT06749431
- Status
- Enrolling By Invitation
Conditions
- Meniscus Disorder
- Meniscus Tear
- Patient Satisfaction
Eligibility Criteria
- Sex
- ALL
- Age
- 10 Years - 65 Years
- Healthy Volunteers
- Not accepted
Study Details
The MERCuRE (MEniscus, REstoration, Conservation, and Repair) group is embarking on a 20-year follow-up study to evaluate the clinical outcomes, graft longevity, and chondral protection following primary or revision Meniscal Allograft Transplantation surgery This clinical investigation is a prospective, primary observational, open-label, non-randomized, multi-center study. It is designed to collect clinical follow-up data on patients
Key Dates
- Start date
- Jan 5, 2025
- Status verified
- Dec 2024
- Primary completion
- Jan 5, 2030
- Completion
- Jan 5, 2050
Study Design
- Enrollment
- 5,000 participants (estimated)
Primary Outcome Measure
Evaluation of PROM: The Knee Injury and Osteoarthritis Outcome (KOOS) Score [ Time Frame: 3 months, 6 months, 1 year, 2 years, 5 years, 10 years, 15 years, and 20 years post-operatively ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Health | Plano | Texas | 75024 | - |
Find similar trials in Plano, TX
By research site
Related Studies
- Outcomes of Meniscus Root Repair Using a Transtibial Pullout TechniqueEnrolling By Invitation · Mayo Clinic · Rochester, Minnesota
- Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)Recruiting · Minneapolis Heart Institute Foundation · San Francisco, California
- MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)EARLY_PHASE1 · Recruiting · Austin V Stone · Lexington, Kentucky
- Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal HealingPHASE1/PHASE2 · Recruiting · University of Cincinnati · Cincinnati, Ohio